Posts Tagged: march in petition


Fine Tuning the Trump Administration’s ROI Initiative

The Trump Administration's Return on Investment (ROI) Initiative, which is geared toward increasing the American taxpayer's benefits from federally-supported R&D, is potentially a big step forward. …
By Joseph Allen
10 months ago 0

Property Rights Key to Bayh-Dole Act’s Success

The focus of the political advocates pushing march-in may be lower drug costs. But the long-term costs of ripping apart IP rights are far higher and more …
By James Edwards
3 years ago 5

NIH Director Collins Stands Up to the March in Mob

The problem with this theory is that the Bayh-Dole Act does not provide agencies the authority to regulate product prices. The law allows universities and contractors to …
By Joseph Allen
3 years ago 0

When Government Tried March In Rights To Control Health Care Costs

As we await the decision from the National Institutes of Health (NIH) on the petition backed by Senator Bernie Sanders and others urging that the march in …
By Joseph Allen
4 years ago 10

NIH Pressured to Misuse Bayh-Dole to Control Drug Prices

Secretary Burwell and Director Collins are facing formidable pressure to reinterpret the Bayh-Dole Act for the compulsory licensing of costly drugs arising from federally supported research. And …
By Joseph Allen
4 years ago 6

Bayh-Dole Under March-in Assault: Can It Hold Out?

The new year was hardly underway before Representative Lloyd Doggett (D-TX) and 50 of his House colleagues sent a letter to Health and Human Services Secretary Sylvia Burwell …
By Joseph Allen
4 years ago 0

Hunting Bayh-Dole Vampires

The government is funding basic research at universities, not drug development. Bayh-Dole allows schools to own resulting inventions and license them for commercialization. These discoveries are more …
By Joseph Allen
6 years ago 1

NIH Gets It Right: Bayh-Dole is not for Price Controls

The National Institutes of Health recently made its long anticipated ruling on a petition seeking to use the “march in” provisions of the Bayh-Dole Act as a …
By Joseph Allen
6 years ago 1

High Noon for Bayh-Dole

Senate Judiciary Committee Chairman Patrick Leahy (D-VT) asked NIH in a July 12 letter to force compulsory licensing of Myriad’s BRCA breast and ovarian cancer genetic test …
By Joseph Allen
6 years ago 3

Plucking the Golden Goose Won’t Help Patients

Several public interest groups recently filed a march in petition under the Bayh-Dole Act asking NIH to force Abbott Laboratories to license its competitors for the production …
By Joseph Allen
7 years ago 5